Filetype
PURPOSE The ESPAC4 trial showed that adjuvant chemotherapy with gemcitabine plus capecitabine (GemCap) produced longer overall survival (OS) than gemcitabine monotherapy. Subsequently, the PRODIGE24-CCTG PA.6 trial showed even longer survival for modified fluorouracil, folinic acid, irinotecan, and oxaliplatin (mFOLFIRINOX) than gemcitabine but had more restrictive eligibility criteria. Our aim wa
Background: There are few large register-based studies on people with intellectual disabilities (ID) that compare outcomes with the general population. Methods: All people in Skåne, the southernmost part of Sweden the 1st of January 2014 was included. Data concerning demographics/vital events, healthcare utilization and service and support for people with ID or autism spectrum disorder (ASD) was c
Licensed human papillomavirus (HPV) vaccines, based on virus-like particles (VLPs) self-assembled from major capsid protein L1, afford type-restricted protection against HPV types 16/18/6/11 (or 16/18 for the bivalent vaccine), which cause 70% of cervical cancers (CxCas) and 90% of genital warts. However, they do not protect against less prevalent high-risk (HR) types causing 30% of CxCa, or cutan
Background: Hip and groin problems are common in ice hockey but studies on professional female players are sparse. The available literature describes hip and groin problems by reporting incidence of time-loss injuries and may thereby underestimate the scope of these problems, which are often due to overuse and may not lead to absence from ice hockey participation.Purpose: The purpose of this study
Profilområdesmedlem Kontaktinformation E-post: jana [dot] canavan [at] svet [dot] lu [dot] seOrganisation LU profilområde: Mänskliga rättigheter WebbplatsJana Canavans profil i Lunds universitets forskningsportalAndra roller Affilierad Statsvetenskapliga institutionenStatsvetenskapForskningsintressenmänniskor-djur-relationerkritiska djurstudierintersektionalitetmiljöpolitik Publikationer Visar a
https://www.svet.lu.se/jana-canavan - 2026-05-06
EBSCO Discovery Service for Academic www.ebsco.com1 Tips, trix and tools Alex Butler, abutler@ebsco.com www.ebsco.com2 • Polls – mentimeter • EDS “hälsokontroll” • Features to highlight • Roadmap Our session today (40 mins) www.ebsco.com3 Health check on your EBSCO platforms www.ebsco.com4 www.ebsco.com5 www.ebsco.com6 Search optimization www.ebsco.com7 www.ebsco.com8 www.ebsco.com9 www.ebsco.com1
https://www.ub.lu.se/sites/ub.lu.se/files/2024-05/eds-tips-and-trix-alex-butler.pdf - 2026-05-07
Postadress Box 117, 221 00 Lund Besöksadress Medicon Village, Scheeletorget 1,223 63 Lund Telefon 046-222 12 51, 046-222 00 00 E- post linus.wiebe@innovation.lu.se Webbadress www.lu.se Univers i tetsstyrelsen Ägardirektiv för LU Holding AB Fastställes av universitetsstyrelsen 2024-06-18 Detta dokument avser att på ett övergripande plan reglera hur Lunds universitet (LU) ska utöva sin roll som ägar
https://www.innovation.lu.se/sites/innovation.lu.se/files/2024-08/A%CC%88gardirektiv%20LU%20Holding%20AB%20240618.pdf - 2026-05-07
TEDDY Årsrapport 2015 1 Årsrapport 2015 TEDDY – Omgivningsfaktorers betydelse för typ 1-diabetes och celiaki hos barn Malmö Kristianstad Helsingborg TEDDY-lab Malmö Ystad Simrishamn TEDDY Årsrapport 2015 2 Innehållsförteckning 1. Sammanfattning 2. Bakgrund TEDDY-studien 3. Typ 1-diabetes är en sjukdom i två steg 4. Glutenintolerans – celiaki - utvecklas också i två steg 5. TEDDY-studiens organisat
https://www.teddy.lu.se/sites/teddy.lu.se/files/2015_teddy_arsrapport.pdf - 2026-05-07
MIDA11 Schedule Autumn 2018 MIDA11 – International Development Perspectives Autumn 2018 Date Time Venue Theme Activity Group Facilitator 3/9 9-12 128 LUMID Programme Introduction Intro All SS/SV/AK/VR MODULE 1: DEVELOPMENT THEORY 3/9 12-13 128 Development in historical perspective Lec All SS 5/9 10-12 128 Critical theories of development Lec All CG 6/9 10-12 111 Theory and development practice Lec
https://www.keg.lu.se/sites/keg.lu.se/files/mida11_schedule_autumn_2018.pdf - 2026-05-07
